Rational Pharmacotherapy in Cardiology

Advanced search


Full Text:


Dobutamine is inotropic drug indicated in systolic dysfunction. Data on dobutamine pharmacology, its effects on hemodynamics, coronary and peripheral blood flow, myocardial electrophysiology are presented. Clinical usage and the main contraindications of dobutamine are discussed.

About the Author

M. Yu. Giljarov
Moscow Medical Academy named after M.I. Setchenov, Bolshaya Pirogovskaya ul 6, Moscow, 119992 Russia
Russian Federation
Chair of preventive and emergency cardiology


1. Ruffolo R.R. Jr. The mechanism of action of dobutamine. Ann Intern Med 1984;100(2):313-4.

2. Taylor D.O. et al. Dobutamine. In: Messerli F. H., editor. Cardiovascular drug and therapy. Philadelphia: W B Saunders Company; 1990.

3. Opie L. H., Gersh B. J., editors. Drugs for the heart. Philadelphia: Saunders-Elsevier; 2008.

4. Гилман А. Г., редактор. Клиническая фармакология по Гудману и Гилману. М.: Практика; 2006.

5. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29(9):2388-442.

For citation:

Giljarov M.Yu. DOBUTAMINE USAGE IN CARDIOLOGICAL PRACTICE. Rational Pharmacotherapy in Cardiology. 2008;4(5):67-70. (In Russ.)

Views: 357

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)